(15046889), K. E. H., (15046892), X. W., (15046895), J. S. R., (15046898), D. J. L., (15046901), N. E. S., (15046904), W. J. F., . . . (15046970), M. E. Y. (2025). Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
Style de citation Chicago (17e éd.)(15046889), Katie E. Hebron, et al. Supplementary Data File S6 from The Combination of Trametinib and Ganitumab Is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models. 2025.
Style de citation MLA (9e éd.)(15046889), Katie E. Hebron, et al. Supplementary Data File S6 from The Combination of Trametinib and Ganitumab Is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models. 2025.
Attention : ces citations peuvent ne pas être correctes à 100%.